Cosmos Health COSM
NASDAQ COSM
$0.39 -0.04 (-10.19%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cosmos Health (COSM) Research & Development (2024 - 2026)

Updated

Cosmos Health (COSM) recorded Research & Development of $68,552 in Q2 2026, down 8.2% from $74,637 a year earlier.

Analysis

Cosmos Health (COSM) Research & Development (2024 - 2026) Analysis & Trends

On a TTM basis, Cosmos Health's Research & Development came in at $497,649 as of Jun 30, 2026, down 20.2% year-over-year; for FY2025, it was $519,363, down 2.6% from FY2024.

  • Across earlier years, Research & Development came in at $533,293 in FY2024 (+223.5%) and $164,859 in FY2023.
  • Quarterly Research & Development has ranged from $15,629 in Q1 2025 to $533,293 in Q4 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 3.65 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.34 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -4.05 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.76 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 993.80 Mn
10 Cosmos Health 25.77 Mn 21.70 Mn 1.51 Mn 68,552.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68,552.00
Dec 31, 2025 410,760.00
Sep 30, 2025 18,337.00
Jun 30, 2025 74,637.00
Mar 31, 2025 15,629.00
Dec 31, 2024 533,293.00
API Access

Cosmos Health Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=COSM&period=max&api_key=YOUR_API_KEY